Mandate

Vinge advised Fortum Värme in connection with the Swedish Competition Authority’s three-year investigation regarding the price of district heating in Stockholm

November 15, 2010

Since October 2007 the Swedish Competition Authority has investigated whether Fortum Värme, jointly owned by Fortum and the City of Stockholm, abused a dominant position in breach of the Swedish Competition Act by imposing unfairly high prices (excessive pricing) on its district heating customers in the Stockholm area. The Competition Authority has, by its unconditional decision on 12 November 2010, now closed the extensive and detailed investigation without any further actions. Fortum Värme has, during the investigation, declared its intention to ensure, for 2011, that the revenues generated from its district heating operations in Stockholm do not exceed a revenue cap defined by the company.     

Vinge’s competition team included responsible partner Johan Karlsson and several associates, including Carl Johan Sundqvist and Emil Fahlén Godö. Part of the team was also associate professor Mattias Ganslandt who, inter alia, contributed with several economic reports concerning the market for district heating and Fortum Värme’s pricing.

The Swedish Competition Authority’s decision and press release

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025